Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania

E E Maro1, M Janabi, R Kaushik

  • 1Muhimbili University College of Health Sciences, PO Box 65202, Dar es Salaam, Tanzania.

Tropical Doctor
|October 13, 2006
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is rare in published African reports. Echocardiography revealed HCM in 0.19% of patients, highlighting the need for this diagnostic tool.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Published reports on hypertrophic cardiomyopathy (HCM) in African populations are scarce.
  • Limited access to echocardiography equipment in many African hospitals contributes to underdiagnosis.

Purpose of the Study:

  • To determine the prevalence of hypertrophic cardiomyopathy (HCM) in patients referred for echocardiography in Tanzania.
  • To emphasize the diagnostic utility of echocardiography for HCM.

Main Methods:

  • Retrospective analysis of 6680 echocardiography referrals at Muhimbili National Hospital from June 1998 to October 2002.
  • Diagnosis of HCM based on echocardiographic findings.

Main Results:

  • Hypertrophic cardiomyopathy (HCM) was diagnosed in 134 (0.19%) patients.
  • The mean age of affected patients was 54.8 years, with 67.9% being male.
  • Only 5.9% of HCM patients received a correct pre-echocardiography diagnosis due to diverse clinical presentations.

Conclusions:

  • Echocardiography is crucial for the accurate diagnosis of hypertrophic cardiomyopathy (HCM).
  • Increased availability of echocardiography is essential for early and precise HCM diagnosis in African settings.
  • Further research is needed to understand HCM prevalence and characteristics in African populations.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...